Introduction to Small Molecule Drug Discovery & Development (Coursera)

Introduction to Small Molecule Drug Discovery & Development (Coursera)

What does it take to advance a new drug from the laboratory bench to the patient’s bedside? Historically, drugs were discovered serendipitously and were usually isolated from natural sources. Today, drug discovery efforts take many years and cost hundreds of millions of dollars. They also require the input of dozens of specialists from a multitude of backgrounds to ensure that therapeutic molecules are efficacious and safe.

Class Deals by MOOC List - Click here and see Coursera's Active Discounts, Deals, and Promo Codes.

This four-week course takes a high-level tour of what it takes to research and develop a new drug. We will meet different scientists and professionals across the drug discovery value chain as we explore the different stages of discovery and development, including the different tools and technologies that are influencing how we think about new medicines today.
Starting off with the needs of the patient and the early phases of drug discovery, we will cover drug metabolism, pharmacokinetics and drug safety all the way to clinical development and beyond. This course is relevant for scientists who are new to drug discovery research or already have some experience, health professionals, or anyone who is interested in knowing what had to happen to ensure that their medicine is effective and safe.

What you'll learn

  • The different stages of drug discovery and development, including the tools and technologies influencing how we think about new medicines.
  • Investigate drug metabolism, pharmacokinetics and drug safety all the way to clinical development and beyond from the needs of the patient.

Syllabus

The starting point for drug discovery: The needs of the patient
This week covers an introduction to the drug discovery and development process. It starts off by considering the patient, as the ultimate beneficiary of new and improved drugs, to ensure that they are kept at the centre of and integrated into all subsequent decision-making. Through a case study, the concept of an unmet medical need is introduced and provides a backdrop for understanding further critical concepts which underlie drug discovery and development. An overview of various drug discovery strategies is presented, along with approaches to screening and hit discovery. Various scientific, medical and humanitarian considerations need to be taken into account if effective delivery of new and improved drugs is to be achieved. Some of the challenges are presented, and a panel discussion highlights different, and similar, perspectives in the academic and industry approach to drug discovery projects.

The early phases of drug discovery
This week explores the early phases of drug discovery. As outlined previously, the starting point is always the needs of the patient and their biomedical realities. Understanding disease biology is a critical next step and sets the scene for mapping the context for immune response and the origins of ill health and how the progression of disease can be controlled or arrested. Case studies, particularly in the context of tuberculosis (TB), demonstrate the rationale behind molecular biology studies of the pathogen and the host. Key concepts such as the essentiality and vulnerability of targets and their 'druggability' are introduced. Medicinal chemistry drives the chemical modification of drug-like molecules to improve their activity and safety. The various tools and approaches that the medicinal chemist has at their disposal, including the value of the screening cascade, will be discussed.

Drug metabolism, pharmacokinetics and drug safety
This week picks up the drug discovery and development story at the point at which promising drug candidates have already been identified. The crucial importance in this phase of investigating the pharmacokinetics and pharmacodynamics of potential drugs is introduced, as these are key parameters for the effectiveness of a new drug and a positive patient experience. These properties have a bearing on bioavailability and metabolic processes and provide a backdrop for animal model studies, and the extent to which the biological properties of the drug are retained in mammalian systems. The ethical considerations and technological advances pertaining to in vivo testing are discussed. Drug testing, safety profiling, and toxicology and efficacy in preparation for clinical trials are presented, and an introduction to process optimization and API manufacturing is also discussed.

Development phase
This week outlines and examines the clinical development phase. Once a drug candidate has successfully progressed through the phases outlined previously, it qualifies for filing as an Investigational New Drug (IND) and a Clinical Trial Application (CTA) and the accompanying review process. An overview is given of the regulatory framework governing this, and a description of the various phases of clinical trials. The extensive teamwork that is required during the clinical trial is outlined, as well as the various role-players in this process, and some of the critical aspects, such as the submission and approval process, protocols that need to be established, informed consent and site management, are described. Finally, we look to the future and consider how new technologies are changing the face of drug discovery and development and how this may ultimately bring newer and safer medicines to the patient more rapidly.

Go to Class
MOOC List is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

Related Courses

Literature Case Studies in Drug Discovery (edX) EdX
Davidson College,DavidsonX

Literature Case Studies in Drug Discovery (edX)

Once a person understands the ideas of drug efficacy, potency, pharmacokinetics, and safety, original research articles can be readily understood. The Journal of Medicinal Chemistry of the American Chemical Society regularly publishes a series of articles called Drug Annotations. These articles summaries a drug discovery program from a pharmaceutical company. The article covers everything from the indication of the drug, key pathways and promising drug targets within the pathways, library screening, lead selection, lead optimization, and both preclinical safety and PK/ADME studies. The articles are excellent articles for students who are testing their knowledge of drug discovery.

Self Paced
Self-Paced
Measuring Pharmacodynamics: From Ligand Binding to Clinical Outcomes (edX) EdX
Davidson College,DavidsonX

Measuring Pharmacodynamics: From Ligand Binding to Clinical Outcomes (edX)

Drugs are biologically active compounds. Drug discovery and drug development rely on methods for measuring biological activity. The term “activity” is quite general. In practice, a substance’s biological activity can refer to how a substance affects a biological pathway, cell-level responses, safety risks, how long a substance resides within in a system, as well as a substance’s effects in an organism (called pharmacodynamics). The design of methods for measuring activity is a critical aspect of drug discovery. The design of robust and informative methods can accelerate the drug discovery and development process.

Self Paced
Self-Paced
Community Change in Public Health (Coursera) Coursera
Johns Hopkins University

Community Change in Public Health (Coursera)

In bringing about behavior change in public health, we often focus on the individual mother, student, or farmer. We should not forget the community structure and norms constrain for encouraging individual health behaviors. This course examines the community context of the changes needed to promote the public’s health. We begin by examining the various definitions of ‘community’ and the processes by which we ‘diagnose’ or seek to understand the structure and characteristics of different types of communities.

Dec 14th 2026
5-12 Weeks
Drug Discovery (Coursera) Coursera
University of California, San Diego

Drug Discovery (Coursera)

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Discovery course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug discovery. In this course you will learn the drug discovery process up to the filing of an Initial New Drug Application or IND. Each week you will learn the steps that a pharmaceutical or biotech company goes through to discover a new therapeutic drug.

Nov 30th 2026
3 Weeks
Case Studies in Personalized Medicine (Coursera) Coursera
Vanderbilt University

Case Studies in Personalized Medicine (Coursera)

Learn how advances in biomedicine hold the potential to revolutionize drug development, drug treatments, and disease prevention: where are we now, and what does the future hold? This course will present short primers in genetics and mechanisms underlying variability in drug responses. A series of case studies will be used to illustrate principles of how genetics are being brought to bear on refining diagnoses and on personalizing treatment in rare and common diseases. The ethical and operational issues around how to implement large scale genomic sequencing in clinical practice will be addressed.

Dec 7th 2026
5-12 Weeks
Synapses, Neurons and Brains (Coursera) Coursera
Hebrew University of Jerusalem

Synapses, Neurons and Brains (Coursera)

These are very unique times for brain research. The aperitif for the course will thus highlight the present “brain-excitements” worldwide. You will then become intimately acquainted with the operational principles of neuronal “life-ware” (synapses, neurons and the networks that they form) and consequently, on how neurons behave as computational microchips and how they plastically and constantly change - a process that underlies learning and memory.

Dec 14th 2026
5-12 Weeks
Drug Commercialization (Coursera) Coursera
University of California, San Diego

Drug Commercialization (Coursera)

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Commercialization course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug commercialization. This course will cover pharmacoeconomic, marketing strategy, intellectual property strategy, portfolio management, managed markets and strategic alliances. It will also have a lecture case study from startup to success.

Dec 7th 2026
4 Weeks
Pharmacology of Antibacterial Agents (Coursera) Coursera
E-Learning Development Fund,RUDN University

Pharmacology of Antibacterial Agents (Coursera)

The online course “Pharmacology of antibacterial agents” has been designed and developed by the team of authors of Department of General and Clinical Pharmacology, Medical Institute of People’s Friendship University of Russia (RUDN University). The main objective of the course is to provide systemic knowledge on pharmacokinetic and pharmacodynamic parameters of the main groups of antibacterial agents and insight into their proper and safe use.

Jul 18th 2022
5-12 Weeks